Lenalidomide as potential treatment in small cell neuroendocrine lung cancer with del 5q
<p>Lung cancer is a leading cause of cancer deaths world-wide, with the carcinogens in tobacco smoke playing a major etiologic role. Genetic changes responsible for carcinogenesis include activation of proto-oncogenes and inactivation of tumor suppressor genes. Tumor suppressor gene inactivati...
Saved in:
Main Author: | Paul Hartel (Author) |
---|---|
Format: | Book |
Published: |
Scientific Journal of Genetics and Gene Therapy - Peertechz Publications,
2018-07-11.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improvement of primary vulvar Langerhans cell histiocytosis with lenalidomide
by: Steven Morrison, BA, et al.
Published: (2021) -
A rare case of metastatic small cell neuroendocrine carcinoma of the lung presenting as isolated thrombocytopenia
by: Adreana DeMarinis, et al.
Published: (2019) -
Severe cutaneous scleromyxedema treated by lenalidomide
by: Théo Brochet, et al.
Published: (2023) -
Potential predictors of immunotherapy in small cell lung cancer
by: Valeria Skopelidou, et al.
Published: (2023) -
Eruptive basal cell carcinoma and lenalidomide: rising awareness among dermatologists
by: Calogero Pagliarello, et al.
Published: (2022)